828
Participants
Start Date
October 19, 2010
Primary Completion Date
February 6, 2012
Study Completion Date
December 27, 2016
GSK1349572 (dolutegravir)
GSK1349572 50 mg taken once daily with or without food
raltegravir
raltegravir 400mg taken twice daily
GSK1349572 Placebo
GSK1349572 placebo taken once daily
ABC/3TC
Abacavir/Lamivudine background therapy once daily
TDF/FTC
Tenofovir/emtricitabine background therapy once daily
raltegravir Placebo
raltegravir placebo taken twice daily
GSK Investigational Site, Darlinghurst
GSK Investigational Site, Surry Hills
GSK Investigational Site, Melbourne
GSK Investigational Site, Turin
GSK Investigational Site, Marseille
GSK Investigational Site, Berlin
GSK Investigational Site, Córdoba
GSK Investigational Site, A Coruña
GSK Investigational Site, Genoa
GSK Investigational Site, Granada
GSK Investigational Site, Washington D.C.
GSK Investigational Site, San Sebastián
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Brescia
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, Alcalá de Henares
GSK Investigational Site, (Móstoles) Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Columbia
GSK Investigational Site, Cartagena (Murcia)
GSK Investigational Site, Atlanta
GSK Investigational Site, Hanover
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Ft. Pierce
GSK Investigational Site, Vigo ( Pontevedra)
GSK Investigational Site, La Laguna (Santa Cruz de Tenerife)
GSK Investigational Site, Seville
GSK Investigational Site, Nantes
GSK Investigational Site, Cona (Ferrara)
GSK Investigational Site, Dortmund
GSK Investigational Site, Rovigo
GSK Investigational Site, Valencia
GSK Investigational Site, Cologne
GSK Investigational Site, Bonn
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, St Louis
GSK Investigational Site, Lyon
GSK Investigational Site, Little Rock
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Denver
GSK Investigational Site, Munich
GSK Investigational Site, Phoenix
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Torrance
GSK Investigational Site, Fürth
GSK Investigational Site, Long Beach
GSK Investigational Site, Levallois-Perret
GSK Investigational Site, Garches
GSK Investigational Site, Le Kremlin-Bicêtre
GSK Investigational Site, Seattle
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Oryol
GSK Investigational Site, Krasnodar
GSK Investigational Site, Lipetsk
GSK Investigational Site, Volgograd
GSK Investigational Site, Saratov
GSK Investigational Site, N.Novgorod
GSK Investigational Site, Perm
GSK Investigational Site, Hillsborough
GSK Investigational Site, Vancouver
GSK Investigational Site, Hamilton
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Rome
GSK Investigational Site, Alicante
GSK Investigational Site, Almería
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Granada
GSK Investigational Site, Murcia
GSK Investigational Site, Mataró
GSK Investigational Site, Birmingham
GSK Investigational Site, Brighton
GSK Investigational Site, Crumpsall, Manchester
GSK Investigational Site, London
GSK Investigational Site, London
Lead Sponsor
Collaborators (2)
Shionogi
INDUSTRY
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY